Hanmi Pharmaceutical announces Clinical Trial Collaboration with MSD to evaluate 'BH3120' in combin...
SEOUL, South Korea, March 17, 2023 /PRNewswire/ -- Hanmi Pharmaceuticals (128940.KS), a subsidiary ...
CDMO business initiated such as mRNA vaccine raw materials·peptides 10 billion KRW invested in Hanm...
SEOUL, South Korea, June 29, 2021 /PRNewswire/ -- Hanmi Pharmaceutical (hereinafter Hanmi) recently...
* Rolontis and Oraxol BLA/NDA approval from U.S. FDA is expected within this year * LAPSTriple ...
SEOUL, South Korea, Jan. 13, 2021 /PRNewswire/ -- Hanmi Pharmaceutical Co., Ltd., announced "endle...
SEOUL, South Korea, Jan. 15, 2020 /PRNewswire/ -- The company, led by President and CEO Se-chang Kw...